The influence of platelets on the promotion of invasion by tumor cells and inhibition by antiplatelet agents

Pancreas

Volumn 29, Issue 2, 2004, Pages 132-140

  Suzuki, Keiichi ^a   Aiura, Koichi ^a   Ueda, Masakazu ^a   Kitajima, Masaki ^a  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Chemoinvasion; Matrix metalloproteinase 9; Metastasis; Pancreatic cancer; Zymography

Indexed keywords

ANTITHROMBOCYTIC AGENT; CILOSTAZOL; GELATINASE B; ICOSAPENTAENOIC ACID; PROSTACYCLIN;

ARTICLE; CANCER CELL CULTURE; CANCER INVASION; CELL COUNT; CELL INVASION; CONTROLLED STUDY; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; METASTASIS INHIBITION; PRIORITY JOURNAL; PROTEIN SECRETION; THROMBOCYTE AGGREGATION; THROMBOCYTE AGGREGATION INHIBITION; ZYMOGRAPHY;

ADENOCARCINOMA; ADENOSINE DIPHOSPHATE; ADULT; BLOOD PLATELETS; CELL LINE, TUMOR; COLLAGEN; DRUG COMBINATIONS; DRUG SCREENING ASSAYS, ANTITUMOR; EICOSAPENTAENOIC ACID; EPOPROSTENOL; HIRUDINS; HUMANS; LAMININ; MATRIX METALLOPROTEINASE 9; NEOPLASM INVASIVENESS; NEOPLASM PROTEINS; PANCREATIC NEOPLASMS; PLATELET ACTIVATION; PLATELET AGGREGATION INHIBITORS; PROTEOGLYCANS; TETRAZOLES; THROMBIN;

EID: 3242763172     PISSN: 08853177     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006676-200408000-00008     Document Type: Article

References (38)

1. Held-Warmkessel J, Volpe H, Waldman AR. Treatment for pancreatic cancer. Clin J Oncol Nurs. 1998;2:127-134.
2. Howard TJ. Pancreatic adenocarcinoma. Curr Probl Cancer. 1996;20:281-328.
3. Costantini V, Zacharski LR, Moritz TE, et al. The platelet count in carcinoma of the lung and colon. Thromb Haemost. 1990;64:501-505.
4. Rodriguez GC, Clarke-Pearson DL, Soper JT, et al. The negative prognostic implications of thrombocytosis in women with stage IB cervical cancer. Obstet Gynecol. 1994;83:445-448.
5. Moller-Pedersen L, Milman N. Prognostic significance of thrombocytosis in patients with primary lung cancer. Eur Respir J. 1996;9:1826-1830.
6. Gasic GJ, Gasic TB, Steward CC. Antimetastatic effects associated with platelet reduction. Proc Natl Acad Sci U S A. 1968;61:46-52.
7. Gasic GJ, Gasic TB, Galanti N, et al. Platelet-tumor-cell interactions in mice. The role of platelets in the spread of malignant disease. Int J Cancer. 1973;11:704-718.
8. Pearlstein E, Salk PL, Yogeeswaran G, et al. Correlation between spontaneous metastatic potential, platelet-aggregating activity of cell surface extracts, and cell surface sialylation in 10 metastatic-variant derivatives of a rat renal sarcoma cell line. Proc Natl Acad Sci U S A. 1980;77:4336-4339.
9. Karpatkin S, Pearlstein E. Role of platelets in tumor cell metastases. Ann Intern Med. 1981;95:636-641.
10. Bastida E, Ordinas A, Giardina SL, et al. Differentiation of platelet-aggregating effects of human tumor cell lines based on inhibition studies with apyrase, hirudin, and phospholipase. Cancer Res. 1982;42:4348-4352.
11. Crissman JD, Hatfield JS, Menter DG, et al. Morphological study of the interaction of intravascular tumor cells with endothelial cells and subendothelial matrix. Cancer Res. 1988;48:4065-4072.
12. Gasic GJ. Role of plasma, platelets, and endothelial cells in tumor metastasis. Cancer Metastasis Rev. 1984;3:99-114.
13. Honn KV, Tang DG, Crissman JD. Platelets and cancer metastasis: a causal relationship? Cancer Metastasis Rev. 1992;11:325-351.
14. Mahalingam M, Ugen KE, Kao KJ, et al. Functional role of platelets in experimental metastasis studied with cloned murine fibrosarcoma cell variants. Cancer Res. 1988;48:1460-1464.
15. Honn KV, Onoda JM, Menter DG, et al. Platelet-tumor cell interaction as targets for antimetastatic therapy. In: Honn KV, Power WE, Sloane BF, eds. Mechanism of cancer metastasis. Boston: Martinus Nijhoff Publishing, 1986:117-144.
16. Honn KV, Busse WD, Sloane BF. Prostacyclin and thromboxanes. Implications for their role in tumor cell metastasis. Biochem Pharmacol. 1983;32:1-11.
17. Liotta LA, Tryggvason K, Garbisa S, et al. Metastatic potential correlates with enzymatic degradation of basement membrane collagen. Nature. 1980;284:67-68.
18. Liotta LA, Stetler-Stevenson WG. Metalloproteinases and cancer invasion. Semin Cancer Biol. 1990;1:99-106.
19. Stetler-Stevenson WG, Liotta LA, Kleiner DE Jr. Extracellular matrix 6: role of matrix metalloproteinases in tumor invasion and metastasis. FASEB J. 1993;7:1434-1441.
20. Poulsom R, Pignatelli M, Stetler-Stevenson WG, et al. Stromal expression of 72 kda type IV collagenase (MMP-2) and TIMP-2 mRNAs in colorectal neoplasia. Am J Pathol. 1992;141:389-396.
21. Zucker S, Lysik RM, Malik M, et al. Secretion of gelatinases and tissue inhibitors of metalloproteinases by human lung cancer cell lines and revertant cell lines: not an invariant correlation with metastasis. Int J Cancer. 1992;52:366-371.
22. Koshiba T, Hosotani R, Wada M, et al. Imamura M. Involvement of matrix metalloproteinase-2 activity in invasion and metastasis of pancreatic carcinoma. Cancer. 1998;82:642-650.
23. Belloc C, Lu H, Soria C, et al. The effect of platelets on invasiveness and protease production of human mammary tumor cells. Int J Cancer. 1995;60:413-417.
24. Lindenmeyer F, Legrand Y, Menashi S. Upregulation of MMP-9 expression in MDA-MB231 tumor cells by platelet granular membrane. FEBS Lett. 1997;418:19-22.
25. Aiura K, Clark BD, Dinarello CA, et al. Interaction with autologous platelets multiplies interleukin-1 and tumor necrosis factor production in mononuclear cells. J Infect Dis. 1997;175:123-129.
26. Albini A, Iwamoto Y, Kleimen H, et al. A rapid in vitro assay for quantitating the invasive potential of tumor cells. Cancer Res. 1987;47:3239-3245.
27. Galt SW, Lindemann S, Medd D, et al. Differential regulation of matrix metalloproteinase-9 by monocytes adherent to collagen and platelets. Circ Res. 2001;89:509-516.
28. Okuda Y, Kimura Y, Yamashita K. Cilostazol. Cardiovasc Drug Rev. 1993;11:58-61.
29. Honn KV, Cicone B, Skoff A. Prostacyclin: a potent antimetastatic agent. Science. 1981;212:1270-1272.
30. Menter DG, Onoda JM, Moilanen D, et al. Inhibition by prostacyclin of the tumor cell-induced platelet release reaction and platelet aggregation. J Natl Cancer Inst. 1987;78:961-969.
31. Schneider MR, Tang DG, Schirner M, et al. Prostacyclin and its analogues: antimetastatic effects and mechanisms of action. Cancer Metastasis Rev. 1994;13:349-364.
32. 2. Prostaglandins. 1980;20:853-861.
33. Pifer DD, Cagen LM, Chesney CM. Stability of prostaglandin I2 in human blood. Prostaglandins. 1981;21:165-175.
34. Inufusa H, Adachi T, Nakamura M, et al. Inhibition of experimental metastasis of human adenocarcinoma by cilostazol, a platelet phosphodiesterase inhibitor. Oncol Rep. 1995;2:1079-1083.
35. Nierodzik ML, Klepfish A, Karpatkin S. Role of platelets, thrombin, integrin IIb-IIIa, fibronectin and von Willebrand factor on tumor adhesion in vitro and metastasis in vivo. Thromb Haemost. 1995;74:282-290.
36. Stone JP, Wagner DD. P-selectin mediates adhesion of platelets to neuroblastoma and small cell lung cancer. J Clin Invest. 1993;92:804-813.
37. Gordon SG. Cancer cell procoagulants and their implications. Hematol Oncol Clin North Am. 1992;6:1359-1374.
38. Steinert BW, Tang DG, Grossi IM, et al. Studies on the role of platelet eicosanoid metabolism and integrin alpha IIb beta 3 in tumor-cell-induced platelet aggregation. Int J Cancer. 1993;54:92-101.